Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (12,6 Mio. €): Einheitlicher Rahmen für patientenzentrierte klinische Studienendpunkte, abgeleitet aus digitalen Gesundheitstechnologien Hor 01.11.2025 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Auf einen Blick

Text

Einheitlicher Rahmen für patientenzentrierte klinische Studienendpunkte, abgeleitet aus digitalen Gesundheitstechnologien

Motivation: Failing to incorporate patient perspectives in healthcare decisions leads to sub-optimal care. Despite increasing emphasis from industry and policy-makers this is not yet common practice. Main objectives: UNIFIED is a public-private partnership involving universities, industry, patient groups, medical centres, HTA bodies, and clinical guideline organisations. It is designed to generate a UNIFIED Framework for obtaining a robust view of a health intervention’s full benefits to patients via (i) integrating three key data types: patient preference information, clinical outcome assessments, and digital health technology (DHT)-derived measures, and (ii) determining what patients consider minimum clinically important difference. Leveraging cutting-edge AI, particularly Foundation Models, UNIFIED integrates these diverse patient-centred data types reliably, while employing advanced safeguards. UNIFIED uses a structured, interactive, and multimethod approach, fostering synergy between academic expertise and fast experience in pharmaceutical and MedTech industry. Validation of the initial framework will occur through well-aligned complementary use cases in five medical domains across Europe and Canada and an adoption approach for patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies. Main deliverables: A robust evidence- and consensus-based UNIFIED Framework with recommendations for integrating patient-centred clinical-study endpoints. The framework will provide clear, actionable guidance for timely and effective use of patient-centred, DHT-derived data as clinical endpoints. Expected long-term impact: Through its evidence- and consensus-based framework and recommendations, UNIFIED empowers patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies to make patient-centred healthcare decisions. This will drive measurable improvements across the healthcare ecosystem, benefitting patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies, and society. Ultimately, UNIFIED will enhance patient-centred care by ensuring healthcare decisions reflect true value to patients, thus improving patient outcomes, while ensuring healthcare’s long-term effectiveness and economic sustainability.


Geförderte Unternehmen:

Firmenname Förderungssumme
Amgen Inc. ?
9197-1168 Quebec IN 0,00 €
Abbvie Inc. 0,00 €
Amgen 0,00 €
Association Europeenne Pour la Maladie de Parkinson 80.000 €
Astrazeneca AB 0,00 €
Cassie and Friends: A Society for Children With Juvenile Arthritis and Other Rheumatic Diseases 80.000 €
Childhood Cancer International 128.563 €
Collaborate Project Management GmbH 300.000 €
Erasmus Universiteit Rotterdam 3.079.810 €
European Academy OF Neurology 80.000 €
F. Hoffmann-LA Roche AG 0,00 €
Fondazione Policlinico Universitario Agostino Gemelli Irccs 600.000 €
Forum des Patients Europeens 329.500 €
Fundacion Publica Andaluza Progreso y Salud M.P 250.000 €
H2O PAN European Observatory 140.000 €
Hochschule Neubrandenburg 599.602 €
HUS-Yhtyma 599.918 €
Iqvia Solutions Belgium 0,00 €
Istituto Europeo Di Oncologia Srl 300.000 €
Janssen Biologics B.V. 0,00 €
John Snow Labs Inc. 0,00 €
Katholieke Universiteit Leuven 600.000 €
Medizinische Universitaet Wien 600.140 €
Molnlycke Health Care AB 0,00 €
Novartis Pharma AG 0,00 €
Novo Nordisk A/S 0,00 €
Pancare 79.875 €
Pfizer Inc. 0,00 €
Prinses Maxima Centrum Voor Kinderoncologie B.V. 487.475 €
Promptly - Software Solutions For Health Measures SA 450.000 €
Siemens Healthineers AG 0,00 €
The European Coalition for People Living with Obesity CLG 80.000 €
The Hospital for Sick Children 16.289,50 €
UCB Biopharma 0,00 €
Universita Degli Studi Di Milano 299.175 €
Universitair Medisch Centrum Utrecht 112.878 €
Universiteit Twente 1.099.996 €
Universiteit Van Amsterdam 650.013 €
University OF Calgary 956.768 €
Uniwersytet Jagiellonski 600.000 €

Quelle: https://cordis.europa.eu/project/id/101218845

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: Amgen Inc., Thousand Oaks, USA.